You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 5, May 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term BP Monitoring in the Evaluation of Antihypertensive Therapy

Jan I. M. Drayer, MD; Michael A. Weber, MD; Janice L. DeYoung; Deborah D. Brewer

Arch Intern Med. 1983;143(5):898-901.


Abstract

• Noninvasive BP monitoring was performed in hypertensive patients before and during placebo therapy and before and during therapy with the long-acting peripheral {alpha}-adrenergic receptor antagonist, terazosin hydrochloride. Placebo therapy did not result in significant changes in casual BP or in averages of whole-day, daytime, or nighttime BPs. Short-term therapy with terazosin did not induce significant changes in casual supine or daytime BPs. However, whole-day BP monitoring disclosed that nighttime BPs were lower during short-term therapy. Moreover, the circadian pattern of BP was shifted downward during terazosin therapy. Long-term therapy with terazosin resulted in significant changes in BP. All BP values were lowered significantly. The differences in the circadian BP pattern between placebo and long-term terazosin therapy show that in these patients BP was lowered throughout the 24 hours of the day. The results of the study emphasize the usefulness of 24-hour BP monitoring in the evaluation of the effectiveness of long-acting antihypertensive agents.

(Arch Intern Med 1983;143:898-901)



Author Affiliations

From the Section of Clinical Pharmacology and Hypertension, Veterans Administration Medical Center, Long Beach, Calif; and the University of California, Irvine.


Footnotes

Accepted for publication Jan 24, 1983.

Reprint requests to the Hypertension Center W130, VA Medical Center, 5901 E Seventh St, Long Beach, CA 90822 (Dr Drayer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ambulatory Monitoring Uncorrected for Placebo Overestimates Long-term Antihypertensive Action
Staessen et al.
Hypertension 1996;27:414-420.
ABSTRACT | FULL TEXT  

Variability of Indirect Methods Used to Determine Blood Pressure: Office vs Mean 24-Hour Automated Blood Pressures
Bottini et al.
Arch Intern Med 1992;152:139-144.
ABSTRACT  

Characterization of Antihypertensive Therapy by Whole-Day Blood Pressure Monitoring
Weber et al.
JAMA 1988;259:3281-3285.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.